Sarepta Therapeutics Inc (SRPT)
113.96
+3.46
(+3.13%)
USD |
NASDAQ |
Nov 22, 12:04
Sarepta Therapeutics Shareholders Equity (Quarterly): 1.221B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.221B |
| June 30, 2024 | 1.077B |
| March 31, 2024 | 961.19M |
| December 31, 2023 | 859.34M |
| September 30, 2023 | 764.36M |
| June 30, 2023 | 741.41M |
| March 31, 2023 | 712.75M |
| December 31, 2022 | 384.95M |
| September 30, 2022 | 430.84M |
| June 30, 2022 | 726.46M |
| March 31, 2022 | 856.89M |
| December 31, 2021 | 928.01M |
| September 30, 2021 | 469.53M |
| June 30, 2021 | 485.11M |
| March 31, 2021 | 535.44M |
| December 31, 2020 | 761.76M |
| September 30, 2020 | 892.05M |
| June 30, 2020 | 1.043B |
| March 31, 2020 | 1.145B |
| December 31, 2019 | 818.19M |
| September 30, 2019 | 995.20M |
| June 30, 2019 | 1.099B |
| March 31, 2019 | 1.349B |
| December 31, 2018 | 1.032B |
| September 30, 2018 | 639.85M |
| Date | Value |
|---|---|
| June 30, 2018 | 699.05M |
| March 31, 2018 | 776.76M |
| December 31, 2017 | 789.22M |
| September 30, 2017 | 697.16M |
| June 30, 2017 | 377.77M |
| March 31, 2017 | 429.14M |
| December 31, 2016 | 336.69M |
| September 30, 2016 | 408.62M |
| June 30, 2016 | 121.46M |
| March 31, 2016 | 138.96M |
| December 31, 2015 | 190.35M |
| September 30, 2015 | 123.24M |
| June 30, 2015 | 165.38M |
| March 31, 2015 | 200.76M |
| December 31, 2014 | 247.65M |
| September 30, 2014 | 286.20M |
| June 30, 2014 | 299.92M |
| March 31, 2014 | 228.96M |
| December 31, 2013 | 247.19M |
| September 30, 2013 | 246.98M |
| June 30, 2013 | 88.82M |
| March 31, 2013 | 87.28M |
| December 31, 2012 | 123.68M |
| September 30, 2012 | -4.566M |
| June 30, 2012 | 22.50M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
384.95M
Minimum
Dec 2022
1.221B
Maximum
Sep 2024
790.70M
Average
791.27M
Median
Shareholders Equity (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 660.94M |
| Madrigal Pharmaceuticals Inc | 777.16M |
| Vertex Pharmaceuticals Inc | 15.63B |
| Viking Therapeutics Inc | 911.45M |
| Regenxbio Inc | 301.42M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.600B |
| Total Liabilities (Quarterly) | 2.379B |
| Debt to Equity Ratio | 1.005 |
| Current Ratio | 3.839 |
| Net Debt Paydown Yield | 0.01% |